Anti-HBV Drugs: Progress, Unmet Needs, and New Hope

Approximately 240 million people worldwide are chronically infected with hepatitis B virus (HBV), which represents a significant challenge to public health. The current goal in treating chronic HBV infection is to block progression of HBV-related liver injury and inflammation to end-stage liver dise...

Descripción completa

Detalles Bibliográficos
Autores principales: Kang, Lei, Pan, Jiaqian, Wu, Jiaofen, Hu, Jiali, Sun, Qian, Tang, Jing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2015
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4584298/
https://www.ncbi.nlm.nih.gov/pubmed/26389937
http://dx.doi.org/10.3390/v7092854

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4584298/
https://www.ncbi.nlm.nih.gov/pubmed/26389937
http://dx.doi.org/10.3390/v7092854

Ejemplares similares